|
1
|
Joshi P, Middleton J, Jeon YJ and Garofalo
M: MicroRNAs in lung cancer. World J Methodol. 2:59722014.
|
|
2
|
Liu R, Liu X, Zheng Y, Gu J, Xiong S,
Jiang P, Jiang X, Huang E, Yang Y, Ge D and Chu Y: MicroRNA7
sensitizes nonsmall cell lung cancer cells to paclitaxel. Oncol
Lett. 5:219322002014.
|
|
3
|
Cai J, Fang L, Huang Y, Li R, Yuan J, Yang
Y, Zhu X, Chen B, Wu J and Li M: miR-205 targets PTEN and PHLPP2 to
augment AKT signaling and drive malignant phenotypes in non-small
cell lung cancer. Cancer Res. 73:5402–5415. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ayaz L, Görür A, Yaroğlu HY, Ozcan C and
Tamer L: Differential expression of microRNAs in plasma of patients
with laryngeal squamous cell carcinoma: potential early-detection
markers for laryngeal squamous cell carcinoma. J Cancer Res Clin
Oncol. 139:1499–1506. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Köhler CU, Bryk O, Meier S, Lang K,
Rozynek P, Brüning T and Käfferlein HU: Analyses in human
urothelial cells identify methylation of miR-152, miR-200b and
miR-10a genes as candidate bladder cancer biomarkers. Biochem
Biophys Res Commun. 438:48–53. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhu Y, Liu XJ, Yang P, Zhao M, Lv LX,
Zhang GD, Wang Q and Zhang L: Alkylglyceronephosphate synthase
(AGPS) alters lipid signaling pathways and supports chemotherapy
resistance of glioma and hepatic carcinoma cell lines. Asian Pac J
Cancer Prev. 7:321932262014.
|
|
7
|
Ulasli SS, Celik S, Gunay E, Ozdemir M,
Hazman O, Ozyurek A, Koyuncu T and Unlu M: Anticancer Effects of
Thymoquinone, Caffeic Acid Phenethyl Ester and Resveratrol on A549
Non-small Cell Lung Cancer Cells Exposed to Benzo(a)pyrene. Asian
Pac J Cancer Prev. 14:6159–6164. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sun PL, Jin Y, Kim H, Seo AN, Jheon S, Lee
CT and Chung JH: Survivin expression is an independent poor
prognostic marker in lung adenocarcinoma but not in squamous cell
carcinoma. Virchows Arch. 463:427–436. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang C, Zhou F, Li N, Shi S, Feng X, Chen
Z, Hang J, Qiu B, Li B, Chang S, et al: Overexpression of RhoE has
a prognostic value in non-small cell lung cancer. Ann Surg Oncol.
14:2628–2635. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Prochazka L, Koudelka S, Dong LF, Stursa
J, Goodwin J, Neca J, Slavik J, Ciganek M, Masek J, Kluckova K, et
al: Mitochondrial targeting overcomes ABCA1-dependent resistance of
lung carcinoma to α-tocopheryl succinate. Apoptosis. 18:286–299.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Minami T, Kijima T, Otani Y, Kohmo S,
Takahashi R, Nagatomo I, Hirata H, Suzuki M, Inoue K, Takeda Y, et
al: HER2 as therapeutic target for overcoming ATP-binding cassette
transporter-mediated chemoresistance in small cell lung cancer. Mol
Cancer Ther. 11:830–841. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang YS, Miao LY, Liu L, Cai HR, Ding JJ,
Ren SX, Zhou CC and Schmid-Bindert G: Serum cytokine levels in
patients with advanced non-small cell lung cancer: correlation with
clinical outcome of erlotinib treatment. Chin Med J (Engl).
126:3931–3935. 2013.
|
|
13
|
Cha Y, Kim DK, Hyun J, Kim SJ and Park KS:
A3 binds to TGF-beta receptor I and induces Smad-independent,
JNK-dependent apoptosis in ovarian cancer cells. Cell Signal.
25:1245–1251. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang K, Zhang Y, Liu C, Xiong Y and Zhang
J: MicroRNAs in the diagnosis and prognosis of breast cancer and
their therapeutic potential. Int J Oncol. 3:9509582014.
|
|
15
|
Li Y, Li L, Guan Y, Liu X, Meng Q and Guo
Q: MiR-92b regulates the cell growth, cisplatin chemosensitivity of
A549 non small cell lung cancer cell line and target PTEN. Biochem
Biophys Res Commun. 440:604–610. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Avasarala S, Bikkavilli RK, Van Scoyk M,
Zhang W, Lapite A, Hostetter L, Byers JT, Heasley LE, Sohn JW and
Winn RA: Heterotrimeric g-protein, gα16, is a critical downstream
effector of non-canonical wnt signaling and a potent inhibitor of
transformed cell growth in non small cell lung cancer. PLoS One.
8:e768952013. View Article : Google Scholar
|
|
17
|
Surowiak P, Pawełczyk K, Maciejczyk A,
Pudełko M, Kołodziej J, Zabel M, Murawa D, Drag M, Gansukh T,
Dietel M and Lage H: Positive correlation between cyclooxygenase 2
and the expression of ABC transporters in non-small cell lung
cancer. Anticancer Res. 28(5B): 2967–2974. 2008.PubMed/NCBI
|
|
18
|
Ak Y, Demirel G and Gülbas Z: MDR1, MRP1
and LRP expression in patients with untreated acute leukaemia:
correlation with 99mTc-MIBI bone marrow scintigraphy. Nucl Med
Commun. 28:541–546. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang L, Deng Q, Wang J, Bai X, Xiao X, Lv
HR, Zhao MF and Liu PJ: Effect of CIK on multidrugresistance
reversal and increasing the sensitivity of ADR in K562/ADR cells.
Oncol Lett. 4:177817822014.
|
|
20
|
Kin R, Kato S, Kaneto N, Sakurai H,
Hayakawa Y, Li F, Tanaka K, Saiki I and Yokoyama S: Procyanidin C1
from Cinnamomi Cortex inhibits TGF-β-induced
epithelial-to-mesenchymal transition in the A549 lung cancer cell
line. Int J Oncol. 43:1901–1906. 2013.PubMed/NCBI
|
|
21
|
Tu B, Peng ZX, Fan QM, Du L, Yan W and
Tang TT: Osteosarcoma cells promote the production of pro-tumor
cytokines in mesenchymal stem cells by inhibiting their osteogenic
differentiation through the TGF-β/Smad2/3 pathway. Exp Cell Res.
320:164–173. 2014. View Article : Google Scholar
|
